Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Brochure More information from http://www.researchandmarkets.com/reports/2671566/ 07 - 2013 Emerging Medical Technologies Report Description: This report includes details on 30 emerging medical technology companies that have been identified by the authors in-house research team in July 2013. All companies include technology, market(s), key executive, and contact information. Coverage includes innovations in a broad spectrum of medical technology areas including: - Aesthetics/Dermatology Companies - Biomaterials Companies - Biotechnology/Cell Therapy Companies - Cardiovascular Companies - Dental Companies - Diagnostics Companies - Drug Delivery Companies - Endocrine Companies - Gastroenterology Companies - Gynecology/Women's Health Companies - Imaging Companies - Neurology Companies - Oncology Companies - Ophthalmology Companies - Orthopedics Companies - Pain Management Companies - Patient Management/Monitoring Companies - Pharmaceutical Companies - Respiratory Companies - Spine Companies - Surgery Companies - Urology Companies - Vascular Companies - Wound Management Companies Contents: BRIEF TECHNOLOGY DESCRIPTIONS FOR COMPANIES COVERED - 1-A liquid biopsy, for the isolation, enumeration, and retrieval of viable circulating tumor cells (CTCs) from blood and 2-A cell-based in vitro diagnostic device for the cancer research market - 1-Diagnostic assays for the practical delivery of personalized medicine and 2-Companion diagnostics (CDx) - A bioresorbable scaffold for treating peripheral artery disease (PAD) in the superficial femoral artery (SFA) - A humanized monoclonal antibody with a unique mechanism of action, which is being developed for the treatment of Inflammatory Bowel Disease (IBD), Rheumatoid Arthritis (RA), and other autoimmune diseases - A line of innovative consumer-oriented ear products based on a drug delivery system that addresses the inherent limitations of ear drops - A temporary wound closure device to control severe bleeding within seconds of application at the point-ofinjury - Ambient Assisted Living System (AALS) that monitors a senior's daily activity by observing usage of any 3 electrical appliances, such as: a microwave, television, or lamp - An advanced, continuous, automatic, and real-time breath-testing platform that enables the detection of the Helicobacter pylori bacteria, assessment of liver function across a range of clinical conditions, and gastric emptying - Anti-bacterial barrier technology to reduce recurrent urinary tract infections (UTIs) in women - Biologic medicines primarily for the treatment of oncology and inflammatory diseases - Computer-based systems that provide a quick, accurate, non-invasive, and low-cost method for the early detection of Alzheimer's Disease (AD) and for precise measurement of disease progression - Dental and orthopedic implant products - Devices for diagnosing and treating swallowing disorders - Drug design strategies delivered via unique dermal product solutions to treat neurological and a variety of other disorders - External tissue expansion devices for the wound care market - First-in-class cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors - Fractional flow reserve (FFR) guidewire that provides an easier, more effective, and more affordable way to obtain FFR measurements during coronary catheterization procedures - Home-use devices incorporating a proprietary platform technology for the treatment of obstructive sleep apnea (OSA) and other sleep-related disorders - Minimally invasive device-based therapies for treating chronic diseases - Minimally invasive energy-based treatment approach (electroporation) that causes tumor tissue to become up to 1000-fold more porous and capable of absorbing certain chemotherapy drugs without damaging healthy tissues - Minimally invasive treatment for nasal valve collapse - Neurostimulation technology for the treatment of chronic respiratory insufficiency: 1-from spinal cord injuries, 2-from muscular dystrophies (such as Amyotrophic Lateral Sclerosis, ALS, Lou Gehrig's Disease), and 3-in a short-term intensive care setting - Non-invasive and non-pharmacologic technology that treats or prevents symptoms of serious headache conditions and bronchoconstriction by sending a mild electrical signal through the skin to stimulate the vagus nerve - Personal hygiene product for the discreet protection of accidental bowel leakage - Platform technology that enables local, targeted delivery of botulinum toxin (Botox) and other potent macromolecules across the skin without patches, needles or other invasive procedures - Proprietary technology for the oral delivery of drugs presently administered by way of injection - Pulmonary vein implants for treating atrial fibrillation (AF) - Quality spine products for treating serious orthopedic medical conditions in a cost-effective manner - Technology for heart repair procedures - Wirelessly powered micro implantable stimulators to provide pain relief Ordering: Order Online - http://www.researchandmarkets.com/reports/2671566/ Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland. Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit http://www.researchandmarkets.com/contact/ Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: 07 - 2013 Emerging Medical Technologies Report Web Address: http://www.researchandmarkets.com/reports/2671566/ Office Code: SCHL3FA7 Product Formats Please select the product formats and quantity you require: Quantity Electronic (PDF) Single User: USD 199 Electronic (PDF) Enterprisewide: USD 1195 Contact Information Please enter all the information below in BLOCK CAPITALS Title: First Name: Mr Mrs Dr Miss Last Name: Email Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL) Ms Prof Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an email with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Pay by wire transfer: Please transfer funds to: Account number 833 130 83 Sort code 98-53-30 Swift code ULSBIE2D IBAN number IE78ULSB98533083313083 Bank Address Ulster Bank, 27-35 Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World